Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B
NCT04629976
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
21
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
DRUG:
NCO-48 Fumarate 4 mg
DRUG:
NCO-48 Fumarate 20 mg
DRUG:
Tenofovir Alafenamide 25 mg
Sponsor
Nucorion Pharmaceuticals, Inc.
Collaborators
[object Object]